June 3, 2011 – New long-term data from the DIVERGE study, presented at EuroPCR 2011, showed that the use of the Axxess drug-eluting stent (DES) for the treatment of complex coronary bifurcation lesions resulted in low levels of both major adverse coronary events (MACE) over a three-year period. Axxess is a self-expanding bifurcation stent that releases Biolimus A9 from an abluminal biodegradable polymer coating.

June 3, 2011 - IDEV Technologies announced that data from a long lesion study of 182 patients with significantly diseased superficial femoral arteries and popliteal arteries showed high patency rates and no stent fractures after treatment with the Supera Veritas Peripheral Vascular Stent System. The data were presented at the Vaatdagen 2011 (Vascular Days) Conference based on analysis by Andre Molenaar, M.D., and Peter Haarbrink, M.D., interventional radiologists at Canisius-Wilhelmina Ziekenhuis (CWZ) hospital, a leading teaching and high volume medical center in Nijmegen, The Netherlands.

June 3, 2011 – At the Society of Imaging Informatics Management (SIIM) meeting, Novarad introduced NovaCardio, a fully integrated cardiac picture archiving and communications system (CPACS) image and information management system. It offers fast and efficient clinical workflow, powerful features and is accessible anywhere viewing and reporting.

June 3, 2011 - Research presented at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary syndromes. Troponin is a protein found inside heart cells that is released when they are damaged by ischemia or reduced blood supply.

June 3, 2011 -- Maquet Cardiovascular announced that the U.S. Food and Drug Administration (FDA) has granted the company 510(k) clearance to market its CardioRoot aortic graft in the United States. A one-piece design, aortic root graft, CardioRoot will be used by vascular and cardiovascular surgeons to surgically repair or replace diseased and damaged aortae. CardioRoot is now commercially available in the United States.

June 3, 2011 – European CE mark approval was granted to expand use of the VerifyNow point-of-care P2Y12 test platelet reactivity test to identify patients who are poor-responders to antiplatelet therapy (e.g. clopidogrel).

June 2, 2011 – The U.S. Food and Drug Administration (FDA) this week is warning medical professionals and U.S. medical device vendors to beware of possible safety concerns and radioactive contamination of medical devices and components coming from Japan.

June 3, 2011 - In a two studies published recently in Heart Rhythm Society annual meeting, Investigators from the department of cardiology in Addenbrooke's Hospital in Cambridge, U.K., found that Cheetah Medical's Nicom system is an effective and practical method for optimizing the function of cardiac resynchronization therapy (CRT) pacemakers.

May 31, 2011 – Boston Scientific Corp. announced it is voluntarily recalling all of its iCross intravascular ultrasound (IVUS) coronary imaging catheters. The company said there have been several occurrences of the catheter tip detaching due to embrittlement of the catheter material.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now